ClassID:

20486

A61K31/612 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid

Sub-classes:
Recent Application in this class:
#1
20240165148
2024-05-23

HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

#2
20220096370
2022-03-31

HIGH PENETRATION COMPOSITION AND USES THEREOF

#3
20210308153
2021-10-07

Halogenated salicylanilides for treating infections

#4
20200093839
2020-03-26

Halogenated salicylanilides for treating infections

#5
20190313934
2019-10-17

DEVICE AND SYSTEM FOR MONITORING AND TREATING MUSCLE TENSION-RELATED MEDICAL CONDITIONS

#6
20180207179
2018-07-26

Halogenated salicylanilides for treating clostridium infections

#7
20180126044
2018-05-10

Antimicrobial compositions and methods for locking catheters

#8
20170151337
2017-06-01

High penetration composition and uses thereof

#9
20160213818
2016-07-28

Antimicrobial compositions and methods for locking catheters

#10
20120321720
2012-12-20

Therapeutic application of parenteral krill oil

#11
20120225931
2012-09-06

Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods

#12
20110212173
2011-09-01

Controlled Release Treatment of Depression

#13
20100286222
2010-11-11

USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS

#14
20090221703
2009-09-03

HIGH PENETRATION COMPOSITION AND USES THEREOF

#15
20070202177
2007-08-30

Antimicrobial Compositions and Methods for Locking Catheters

#16
20070196350
2007-08-23

Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment

#17
20070196288
2007-08-23

Method of treating periodontitis and of reducing dentinal sensitivity

#18
20060178347
2006-08-10

Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors